In a previous study, we demonstrated that cancer cell-derived EVs (TEVs) from melanoma cells and melanoma patients downregulated the type 1 interferon receptor subunit 1 (IFNAR1), resulting in loss of the interferon-stimulated gene (ISG) cholesterol-25 hydroxylase (CH25H)[13]. The gene discussed is CH25H; the disease is melanoma.